| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1965) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 49G3001BCK |
| Parent Compound: | NAFCILLIN |
| InChI Key | AYAPZOUDXCDGIF-FRFVDRIFSA-M |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H23N2NaO6S |
| Molecular Weight | 454.48 |
| AlogP | 2.48 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 95.94 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Penicillin-binding protein inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 35.3 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -28.32-5.86 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 114.4 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteomyelitis | 1 | D010019 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 51919 |
| ChEMBL | CHEMBL1568276 |
| EPA CompTox | DTXSID7045570 |
| FDA SRS | 49G3001BCK |
| PubChem | 23704143 |
| SureChEMBL | SCHEMBL65687 |